Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Lim

Showing results (71-80 of 1,210) with videos related to

Pageof 121
Sort By:
The Korean Journal of Internal Medicine|June 24, 2016
Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopeniaKyoung Min Kim, Hak Chul Jang, Soo Lim
American Journal of Hypertension|May 27, 2011
Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sampleKi-Chul Sung, Soo Lim, Robert S Rosenson
Journal of Physical Therapy Science|February 26, 2014
A study on dispersion and rate of fat infiltration in the lumbar spine of patients with herniated nucleus polpususBong-Jun Kong, Jong-Soo Lim, Kyung Kim
Frontiers in Endocrinology|September 25, 2020
Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-AnalysisYoon Ji Kim, Seun Deuk Hwang, Soo Lim
Trends in Endocrinology and Metabolism: TEM|February 22, 2018
Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual PatternsSoo Lim, Kyoung Min Kim, Michael A Nauck
Nature Reviews. Endocrinology|September 11, 2025
Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitorsYong-Ho Lee, Soo Lim, Melanie J Davies
Diabetes & Metabolism Journal|June 11, 2025
Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health PerspectivesSoo Lim, Ga Eun Nam, Arya M Sharma
Primary Care Diabetes|July 27, 2021
Influence of COVID-19 pandemic and related quarantine procedures on metabolic riskSoo Lim, Alice Pik-Shan Kong, Jaakko Tuomilehto
Journal of Obesity & Metabolic Syndrome|September 1, 2022
Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World SettingHae-Jin Ko, Jin-Wook Kim, Soo Lim
Diabetes, Obesity & Metabolism|December 15, 2021
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effectsSoo Lim, Minji Sohn, Yujin Shin, et al.
Pageof 121

Showing results (71-80 of 1,210) with videos related to

Sort By:
Pageof 121
The Korean Journal of Internal Medicine|June 24, 2016
Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopeniaKyoung Min Kim, Hak Chul Jang, Soo Lim
American Journal of Hypertension|May 27, 2011
Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sampleKi-Chul Sung, Soo Lim, Robert S Rosenson
Journal of Physical Therapy Science|February 26, 2014
A study on dispersion and rate of fat infiltration in the lumbar spine of patients with herniated nucleus polpususBong-Jun Kong, Jong-Soo Lim, Kyung Kim
Frontiers in Endocrinology|September 25, 2020
Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-AnalysisYoon Ji Kim, Seun Deuk Hwang, Soo Lim
Trends in Endocrinology and Metabolism: TEM|February 22, 2018
Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual PatternsSoo Lim, Kyoung Min Kim, Michael A Nauck
Nature Reviews. Endocrinology|September 11, 2025
Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitorsYong-Ho Lee, Soo Lim, Melanie J Davies
Diabetes & Metabolism Journal|June 11, 2025
Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health PerspectivesSoo Lim, Ga Eun Nam, Arya M Sharma
Primary Care Diabetes|July 27, 2021
Influence of COVID-19 pandemic and related quarantine procedures on metabolic riskSoo Lim, Alice Pik-Shan Kong, Jaakko Tuomilehto
Journal of Obesity & Metabolic Syndrome|September 1, 2022
Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World SettingHae-Jin Ko, Jin-Wook Kim, Soo Lim
Diabetes, Obesity & Metabolism|December 15, 2021
Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effectsSoo Lim, Minji Sohn, Yujin Shin, et al.
Pageof 121